Observational studyTherapeutic advances in respiratory disease

A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT).

Shih-Lung Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.